Cargando…

Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells

BACKGROUND: Cancer-associated fibroblasts (CAFs) are vital components of gastric cancer (GC) microenvironments, which impact the aggressive characteristics of GC cells. The objective of this study is to evaluate the influence of High Mobility Group Box (HMGB) on CAF-related GC. METHODS: The tissues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Yanzhuang, Mai, Jieying, Liu, Zhendong, Xu, Yuyang, Zhao, Chunyi, Wang, Baochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660028/ https://www.ncbi.nlm.nih.gov/pubmed/36388689 http://dx.doi.org/10.21037/jgo-22-723

Ejemplares similares

MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1
por: Liu, Po-Len, et al.
Publicado: (2017)

Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer
por: KUANG, YAN, et al.
Publicado: (2013)

Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
por: Ireland, Lucy V., et al.
Publicado: (2018)

Deregulated expression of microRNA-200b/c and SUZ12, a Polycomb repressive complex 2 subunit, in chemoresistant colorectal cancer cells
por: San, KayKay, et al.
Publicado: (2017)

NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer
por: Chung, Hsin-Hua, et al.
Publicado: (2020)

HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer
por: Huang, Chih-Yang, et al.
Publicado: (2018)

Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
por: Lai, Weixin, et al.
Publicado: (2021)

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
por: Cochrane, Dawn R., et al.
Publicado: (2010)

HMGB1 Release and Redox Regulates Autophagy and Apoptosis in Cancer Cells
por: Tang, Daolin, et al.
Publicado: (2010)

The mechanism of HMGB1 secretion and release
por: Chen, Ruochan, et al.
Publicado: (2022)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering miR‐200 levels in extracellular vesicles
por: Bhome, Rahul, et al.
Publicado: (2022)

miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2
por: An, Y, et al.
Publicado: (2015)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer
por: Hu, Yibing, et al.
Publicado: (2015)

HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells
por: Zhou, Junmin, et al.
Publicado: (2015)

Regulation of HMGB1 Release in Health and Diseases
por: Wang, Haichao
Publicado: (2022)

Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
por: Dudás, József, et al.
Publicado: (2020)

Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX
por: Escalante, Paula I., et al.
Publicado: (2021)

FIP200 is Involved in Murine Pseudomonas Infection by Regulating HMGB1 Intracellular Translocation
por: Li, Yi, et al.
Publicado: (2014)

Eukaryotic HMGB proteins as replacements for HU in E. coli repression loop formation
por: Becker, Nicole A., et al.
Publicado: (2008)

Construction of a Prognostic Model Based on Methylation-Related Genes in Patients with Colon Adenocarcinoma
por: Liu, ZhenDong, et al.
Publicado: (2023)

Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance
por: Garvey, Colleen M., et al.
Publicado: (2020)

MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression
por: Zhang, Jing, et al.
Publicado: (2016)

Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells
por: Hu, Lanlin, et al.
Publicado: (2021)

Overexpression of lncRNA HOXA11-AS promotes cell epithelial–mesenchymal transition by repressing miR-200b in non-small cell lung cancer
por: Chen, Jian-Hui, et al.
Publicado: (2017)

Identification of pharmacological agents that induce HMGB1 release
por: Liu, Peng, et al.
Publicado: (2017)

Indirect regulation of HMGB1 release by gasdermin D
por: Volchuk, Allen, et al.
Publicado: (2020)

HMGB1 released from nociceptors mediates inflammation
por: Yang, Huan, et al.
Publicado: (2021)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
por: Park, Ji‐Hye, et al.
Publicado: (2019)

HMGB1 induces lung fibroblast to myofibroblast differentiation through NF-κB-mediated TGF-β1 release
por: Wang, Qiong, et al.
Publicado: (2017)

HMGB1 in inflammation and cancer
por: Wang, Shumin, et al.
Publicado: (2020)

Gene interfered-ferroptosis therapy for cancers
por: Gao, Jinliang, et al.
Publicado: (2021)

MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma
por: Pan, Banzhou, et al.
Publicado: (2015)

Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses
por: Arnold, Edward A., et al.
Publicado: (2023)

Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors
por: Chan, J S K, et al.
Publicado: (2018)

Cancer chemoresistance and BAK
por: Fox, Joanna L.
Publicado: (2015)

Chemoresistance in Pancreatic Cancer
por: Zeng, Siyuan, et al.
Publicado: (2019)

MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer
por: Yu, San-Jian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gmopfi5n6s2er3eop6f1dsj9i4